A comprehensive cell-type-specific developmental genetic toolkit for the drosophila visual system

Active Project Grant Awarded Last action

Award ID
R21NS140885
Recipient
Awarding agency
Obligated
$460,000

Award facts

Completion date 89% complete
Place of performance
New York, NY 10012, USA

Award details come from USAspending.gov.

Description

Abstract
(R21) neural progenitors produce an enormous diversity of neuronal and glial cell types to form a functional nervous system. With the advance of single-cell genomic technologies, more and more cell types with distinct transcriptomic signatures have been defined; yet there is a significant lack of genetic tools to identify, label, and manipulate specific cell types for developmental and functional studies. To efficiently and reliably identify useful GAL4 drivers expressed in a single cell type throughout development, we will take advantage of single- cell mrna sequencing (SCRNA-SEQ) and single nucleus RNA/atacseq data to produce GAL4/split-GAL4 lines that provide targeted genetic access throughout development to any and all optic lobe neurons. Aim 1: developing a collection of gene-specific split-GAL4 lines expressed in single cell types in the developing optic lobe. Our scmarco pipeline allows US to identify marker gene pairs in SCRNA-SEQ data whose overlap selectively labels one specific optic lobe cell type. We will generate split-GAL4S inserted in these gene pairs that reproduce the expression of the genes. Their overlap will generate cell-type specific drivers. We have identified 123 genes to generate split-GAL4S hemi-drivers whose pair combinations can selectively target 81% of all optic lobe cell types. Aim 2: using single-cell multiomics to identify enhancer fragments to generate cell-type-specific drivers. The expression pattern of most genes is controlled by multiple enhancers that each regulate the same gene in different cell types: these enhancers offer high cell-type-specificity. We will use our chromatin accessibility single-cell multiomics (RNA+atac-SEQ) datasets to identify enhancers individually specific to almost any neuron during development that will be cloned to generate GAL4 lines targeting these neuron types. AIM3: combining gene-specific and enhancer-based split-GAL4 lines for complete neuron coverage. As not all cell types can be marked by a combination of gene specific split-GAL4 drivers or by specific enhancers, we will combine the two approaches above to produce tools targeting all cell types in the optic lobe. We will generate split-GAL4 lines with enhancer fragments that will be used in combination with the gene-specific- split-GAL4 lines. This will provide the cellular morphology and thus the identity of the neuron throughout development and will allow manipulation of their function of each neuron. Altogether, this collection of developmental cell-type-specific driver lines will be a valuable resource to study any cell type in the optic lobe, thus powering further developmental and functional studies. The gene- specific split-GAL4 tools (aim 1) can also be used in any tissue of drosophila where single cell transcriptomics is available, thereby expanding the power of this genetic approach to the whole fly community.

Transactions

Action Obligated Date
Amendment $202,250
Original award $257,750

Subawards

Subrecipient Amount Awarded
Stowers Institute For Medical Research Dr. Özel will be responsible for the analysis of the new single-cell multiomics data to identify the regulatory sequences for the generation of full-length… $198,000

Quick answers

Who received award R21NS140885?

R21NS140885 was awarded to New York University by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on February 1, 2025.

How much is award R21NS140885 worth?

$460,000 has been obligated on R21NS140885.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award